Literature DB >> 16637929

Grey matter pathology in multiple sclerosis.

L Bö1, J J G Geurts, S J Mörk, P van der Valk.   

Abstract

Although multiple sclerosis (MS) has been considered a white matter disease, MS lesions are known to occur in grey matter. Recent immunohistochemical studies have demonstrated extensive grey matter demyelination in chronic MS. The most common lesion type consists of purely cortical lesions extending inward from the surface of the brain, this lesion subgroup is grossly underestimated by standard histochemical myelin staining methods. Some MS patients have subpial demyelination in all cortical areas of the brain; this pattern has been termed ''general cortical subpial demyelination''. Extensive cortical demyelination is associated with the progressive phases of disease, as less cortical demyelination has been detected in relapsing-remitting MS. The pathology of grey matter lesions differs from that of white matter lesions; grey matter lesions are less inflammatory, with less macrophage and lymphocyte infiltration. In purely cortical lesions there is no significant increase in lymphocytes compared with non-demyelinated adjacent cortical areas in MS patients or cerebral cortex in control patients. Significant axonal transection and neuronal loss have been demonstrated in grey matter MS lesions. Current magnetic resonance imaging (MRI) methods are not sensitive for purely cortical MS lesions. The clinical significance of cortical MS lesions may not be characterised until more sensitive MRI methods are developed.

Entities:  

Mesh:

Year:  2006        PMID: 16637929     DOI: 10.1111/j.1600-0404.2006.00615.x

Source DB:  PubMed          Journal:  Acta Neurol Scand Suppl        ISSN: 0065-1427


  41 in total

1.  In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI.

Authors:  Caterina Mainero; T Benner; A Radding; A van der Kouwe; R Jensen; B R Rosen; R P Kinkel
Journal:  Neurology       Date:  2009-07-29       Impact factor: 9.910

2.  Thalamus Degeneration and Inflammation in Two Distinct Multiple Sclerosis Animal Models.

Authors:  Nina Wagenknecht; Birte Becker; Miriam Scheld; Cordian Beyer; Tim Clarner; Tanja Hochstrasser; Markus Kipp
Journal:  J Mol Neurosci       Date:  2016-08-04       Impact factor: 3.444

3.  White matter abnormalities: Insights into the pathophysiology of major affective disorders.

Authors:  Gianluca Serafini; Xenia Gonda; Zoltan Rihmer; Paolo Girardi; Mario Amore
Journal:  World J Radiol       Date:  2014-06-28

4.  Alexithymia and impaired facial affect recognition in multiple sclerosis.

Authors:  D Prochnow; J Donell; R Schäfer; S Jörgens; H P Hartung; M Franz; R J Seitz
Journal:  J Neurol       Date:  2011-03-26       Impact factor: 4.849

5.  The neuronal metabolite NAA regulates histone H3 methylation in oligodendrocytes and myelin lipid composition.

Authors:  N K Singhal; H Huang; S Li; R Clements; J Gadd; A Daniels; E E Kooijman; P Bannerman; T Burns; F Guo; D Pleasure; E Freeman; L Shriver; J McDonough
Journal:  Exp Brain Res       Date:  2016-10-05       Impact factor: 1.972

Review 6.  Imaging as an Outcome Measure in Multiple Sclerosis.

Authors:  Daniel Ontaneda; Robert J Fox
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

7.  3D MPRAGE improves classification of cortical lesions in multiple sclerosis.

Authors:  F Nelson; A Poonawalla; P Hou; J S Wolinsky; P A Narayana
Journal:  Mult Scler       Date:  2008-11       Impact factor: 6.312

8.  The role of infections in the pathogenesis and course of multiple sclerosis.

Authors:  Siddharama Pawate; Subramaniam Sriram
Journal:  Ann Indian Acad Neurol       Date:  2010-04       Impact factor: 1.383

9.  Does high-field MR imaging improve cortical lesion detection in multiple sclerosis?

Authors:  Jeroen J G Geurts; Erwin L A Blezer; Hugo Vrenken; Annette van der Toorn; Jonas A Castelijns; Chris H Polman; Petra J W Pouwels; Lars Bö; Frederik Barkhof
Journal:  J Neurol       Date:  2008-02-04       Impact factor: 4.849

Review 10.  Brain extracellular matrix in neurodegeneration.

Authors:  Dafna Bonneh-Barkay; Clayton A Wiley
Journal:  Brain Pathol       Date:  2008-07-25       Impact factor: 6.508

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.